AXGN Q2 2021 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$34M+51.8% YoY

Gross Profit

$26M78.9% margin

Operating Income

-$7M-21.3% margin

Net Income

-$8M-23.5% margin

EPS (Diluted)

$-0.19

QoQ Revenue Growth

+8.2%

Cash Flow

Operating Cash Flow

-$695,000

Free Cash Flow

-$9M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$211M

Total Liabilities

$92M

Stockholders' Equity

$119M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$22M	+51.8%
Gross Profit	$26M	$17M	+60.4%
Operating Income	-$7M	-$8M	+13.3%
Net Income	-$8M	-$8M	+2.6%